3-methanesulfonylquinolines as GABAB enhancers

Details for Australian Patent Application No. 2006254255 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Norcross, Roger David; Masciadri, Raffaello; Malherbe, Parichehr; Prinssen, Eric

Agent Spruson & Ferguson

Pub. Number AU-A-2006254255

PCT Pub. Number WO2006/128802

Priority 05104786.8 02.06.05 EP

Filing date 23 May 2006

Wipo publication date 7 December 2006

International Classifications

C07C 225/22 (2006.01) Compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly-bound oxygen atoms not being part of a CHO group, e.g. amino ketones

A61K 31/47 (2006.01) - Quinolines

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

C07D 215/36 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 215/38 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 215/42 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 265/22 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

6 December 2007 PCT application entered the National Phase

  PCT publication WO2006/128802 Priority application(s): WO2006/128802

22 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006254256-Piperidin-4-yl-amide derivatives and their use as SST receptor subtype 5 antagonists

2006254250-Ex situ and in situ remediation with activated persulfate